WinstonWınston
Back
medmix AG logo

medmix AG

MEDX.SW
36
Medical - Instruments & Supplies · Healthcare
Price
CHF 8.71
-0.16 (-1.80%)
Market Cap
CHF 354.3M
Exchange
SIX Swiss Exchange
Winston Score
36
Winston is serious
Below-average fundamentals — multiple weak pillars.
Data as of Aug 23, 2026 · filings through Jun 30, 2026
How the score breaks down
Quality
Mixed
Growth
Weak
Cash Flow
Strong
Stability
Good
Valuation
Data not available
Dividends
Weak

Winston Score History

The full picture

medmix AG is a Swiss industrial company that makes precision mixing and dispensing devices. These are small tools and systems used to combine two or more substances — like dental adhesives, medical sealants, or industrial glues — right at the moment of use. Its main customers are companies in the healthcare, dental, and industrial sectors that need controlled, accurate mixing of materials.

The company earns revenue by selling its hardware devices and the disposable cartridges and tips that go with them, creating a recurring sales pattern as customers reorder consumables. medmix operates globally, with a strong presence in Europe, North America, and Asia, and generates roughly $400 million in annual revenue. Its competitive position rests on precision engineering and deep customer integration, since switching to a different supplier is costly and disruptive. The key risk is that its low operating margin and weak return on invested capital leave little room for error if volumes decline or raw material costs rise.

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

-4.9% YoY

YoY Growth Rate

Revenue declining

EPS Growth

-92.8% YoY

YoY Growth Rate

Earnings declining

R&D Spend

CHF 20M/ year

Declining (-23% vs prior year)

4.4% of revenue

Below sector average (18%)

R&D spend declining — could signal cost-cutting or efficiency

Insider Activity

40.8%ownership

Flat

Insider ownership roughly steady over the past year

Cash Position

Cash flow positive

CHF 111M cash & investments

Quarterly Free Cash Flow

↓ Burn rate worsening

Company generates more cash than it spends — no dilution risk from fundraising

Revenue declining

medmix AG's revenue is actually shrinking. In a growth stock, that removes the core investment thesis. The low Winston Score here may be warranted — unless there's a turnaround story.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Share count broadly stable

+1.0% over 4y

The share count has stayed roughly flat over this period — little dilution or buyback activity.

Diluted shares outstanding: 41.1M (2021) → 41.5M (2025)

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
37.8%
Modest — 37.8% gross margin
Profit after running costs
Operating Margin
7.7%
Modest — 7.7% operating margin
Return on the money invested
ROCE
4.1%
Weak — 4.1% return on capital

ROIC between 0% and 5%. They earn a few cents back per dollar invested in the business.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
-6.6%
Shrinking sales (-6.6% YoY)
Profit growth
EPS YoY
N/A
Data not available
How steady the profit is
EPS Consistency
3/8 quarters
Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
59300%
Turns 59300% of profit into real cash
Spare cash per sale
FCF Margin
7.3%
Modest free cash flow (7.3%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
0.59
Conservative — low debt load (0.59)
Covers its interest
Interest Cover
2.32x
Tight — interest eats into profit (2.3x)

Interest coverage between 1 and 3. Profits cover interest, but with little room to spare.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
N/A
Data not available
Cheaper or dearer next year
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend
Dividend Yield
1.08%
Small dividend — 1.08% yield

Modest yield. The bulk of any return needs to come from price appreciation.

Dividend record
Dividend Growth
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial